Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy.

J Vasc Surg 2016 Apr 21;63(4):851-7, 858.e1. Epub 2015 Nov 21.

Department of Neurology, Mayo Clinic, Jacksonville, Fla; Department of Surgery, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ. Electronic address:

Objective: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) demonstrated a higher periprocedural stroke and death (S+D) rate among patients randomized to carotid artery stenting (CAS) than to carotid endarterectomy (CEA). Herein, we seek factors that affect the CAS-CEA treatment differences and potentially to identify a subgroup of patients for whom CAS and CEA have equivalent periprocedural S+D risk.

Methods: Patient and arterial characteristics were assessed as effect modifiers of the CAS-CEA treatment difference in 2502 patients by the addition of factor-by-treatment interaction terms to a logistic regression model.

Results: Lesion length and lesions that were contiguous or were sequential and noncontiguous extending remote from the bulb were identified as influencing the CAS-to-CEA S+D treatment difference. For those with longer lesion length (≥12.85 mm), the risk of CAS was higher than that of CEA (odds ratio [OR], 3.42; 95% confidence interval [CI], 1.19-9.78). Among patients with sequential or remote lesions extending beyond the bulb, the risk for S+D was higher for CAS relative to CEA (OR, 9.01; 95% CI, 1.20-67.8). For the 37% of patients with lesions that were both short and contiguous, the odds of S+D in those treated with CAS was nonsignificantly 28% lower than for CEA (OR, 0.72; 95% CI, 0.21-2.46).

Conclusions: The higher S+D risk for those treated with CAS appears to be largely isolated to those with longer lesion length and/or those with sequential and remote lesions. In the absence of those lesion characteristics, CAS appears to be as safe as CEA with regard to periprocedural risk of S+D.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2015.08.119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820245PMC
April 2016
21 Reads

Publication Analysis

Top Keywords

lesion length
12
artery stenting
8
carotid endarterectomy
8
carotid artery
8
stroke death
8
periprocedural stroke
8
treated cas
8
remote lesions
8
treatment difference
8
longer lesion
8
cas-cea treatment
8
sequential remote
8
cas appears
8
risk s+d
8
s+d
7
cas
7
carotid
6
cea
6
patients
5
≥1285 mm risk
4

Similar Publications